Oritavancin + Warfarin Interaction
Moderateinteraction on record
Description
ORBACTIV may affect warfarin concentrations as it inhibits CYP2C9. Patients should be monitored for bleeding signs; however, a drug-drug interaction study showed no effect on S-warfarin Cmax or AUC.
Mechanism
CYP2C9 inhibition
Source: NLP:oritavancin